The development comes at a time when several global companies, including Amazon, Intel and Goldman Sachs, are also cutting ...

The brokerage firm, Goldman Sachs sees light at the end of the tunnel for Indian financials. Even as Indian financial stocks ...

JPMorgan Chase, Wells Fargo, Morgan Stanley, and BlackRock are slated to report earnings on Friday before the market opens.

Goldman Sachs Group Inc. strategists revised higher their forecasts for debt defaults by US junk bond issuers and ...

David Konrad, a KBW equity research analyst, said there were hopes last fall that lower regulations and a surge in animal ...

Gold is sought after because of its scarcity, physical appeal, and popularity. But there is one thing gold does not offer: ...

As agents of financial transactions - from customer checking accounts, to capital-markets trading, to corporate loans in the U.S. and abroad - Wall Street banks have been beaten badly amid the carnage ...

President Donald Trump’s on again, off again approach to tariffs is creating uncertainty that will make oil firms hesitate on investment decisions.

Inflation cooled in March, but economists expect prices to reaccelerate as some of President Trump's tariffs kick in.

Inflation slowed in March as gasoline, used car prices dropped. Trump paused many of his largest tariffs for 90 days but others are taking effect.

U.S. investment bank Goldman Sachs lowered its forecasts for China's GDP growth to 4% in 2025 and 3.5% in 2026 in a report ...

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p15,318.00.